# An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive Chronic Hepatitis B in Vietnam

> **NCT01886300** · — · TERMINATED · sponsor: **Hoffmann-La Roche** · enrollment: 16 (actual)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01886300
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-09
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Due to out-of-date design and non-compliance.
- **Last updated:** 2016-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01886300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01886300, "An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive Chronic Hepatitis B in Vietnam". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01886300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*